AzTrials
AzTrials

Postoperative Cognitive DysfunctionNOMICSNCT02979782

Neurological Outcome After Minimal Invasive Coronary Artery Bypass Graft

An observational study of Postoperative Cognitive Dysfunction and Cerebrovascular Accident, run by Jessa Hospital at 2 sites in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary objectives: Assessment of the incidence of postoperative cognitive dysfunction (POCD), cerebrovascular accident (CVA), and delirium after minimal invasive coronary artery bypass grafting (Endo-CABG). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Endo-CABG and PCI
Type of treatment
Surgery or procedure
How many people
180 participants
Where
2 sitesBelgium
Study dates
Dec 2016to Aug 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The population will be divided into three groups. The first group will be the Endo-CABG group which consist of the patients who undergo minimal invasive coronary artery bypass grafting. The second group consists of patients who will get an elective PCI intervention. this is a comparative group which is included to check whether the assessed prevalences in the Endo-CABG group are not related to underlying cardiac anomalies or to other cardiac intervention procedures. The third group consists of healthy volunteers. This control group will be included to eliminate natural variation in neurophysiological testing and to exclude the learning effect which can occur when repeated neurophysiological testing is performed.

Who may be able to join

  • Minimum age of 18
  • Elective Endo-CABG procedure (group 1)
  • Elective PCI procedure (group 2)
  • Elective healthy volunteer

Who cannot join

  • Medical history of:
  • Postoperative cognitive dysfunction, delirium or cerebrovascular accident
  • symptomatic carotid artery disease
  • Dementia
  • Renal dysfunction: glomular filtration rate (GFR) < 30 ml/min
  • Hepatic dysfunction: serum glutamic-oxaloacetic transaminase (SGOT)/ aspartate aminotransferase (AST), or serum glutamic-pyruvic transaminase (SGPT)/ alanine aminotransferase (ALT), more than three timer higher than normal limits
Show all 12Show fewer
  • History of medication and alcohol abuse
  • Language barrier or incapability to communicate
  • Physical condition making participation impossible
  • Participation in other clinical trials of a drug or medical instrument
  • Surgical revision or intra-operative major cardial event (Endo-CABG group)
  • Conversion to cardiac surgery or intra-operative major event (PCI group)

Trial locations and contacts

2 sites in 1 country.

Belgium2 sites
  • Jessa Hospital

    Hasselt, Limburg, 3500

  • Jessaziekenhuis Hasselt

    Hasselt, Limburg, 3500

Other trials in Belgium

About this study

Official title: Neurological Outcome After Minimal Invasive Coronary Artery Bypass Graft: a Single-centre Prospective Cohort Study

Primary objectives:

Assessment of the incidence of postoperative cognitive dysfunction (POCD), cerebrovascular accident (CVA), and delirium after minimal invasive coronary artery bypass grafting (Endo-CABG).

Secondary objectives:

  • Quality of life, three months after endo-CABG
  • Patient satisfaction with endo-CABG and the tests performed
  • The influence of various demographic and peri-operative variables on neurological outcome after endo-CABG
  • Incidence of fear and depression, 3 months after endo-CABG
Read the detailed description

Introduction:

Major improvements in surgical techniques, perfusion systems, and perioperative policies have led to improved quality of life of the patient, lower hospitalisation costs, and lower mortality rates in the field of cardiac surgery. However, despite these improvements and improved postoperative care, the neurological outcome after cardiac surgery remains a recurrent issue of interest. The most common neurological disorders after cardiac surgery are postoperative cognitive dysfunction (POCD), cerebrovascular accident (CVA), and delirium. After conventional cardiac surgery (invasive sternotomy procedure) the incidence of these neurological disorders is well studied. POCD has an incidence of 25-50%, CVA has an incidence of 1-5% and delirium has an incidence of 5-15%. These numbers prove that neurological outcome still is a major problem after cardiac surgery.

Postoperative cognitive dysfunction (POCD) is the most common neurological disorder after cardiac surgery. POCD is defined as a disturbance of the brain function, which is causally related to surgery. Due to the multifactorial nature of POCD it is difficult to pinpoint one major cause. testing of POCD is not standardised and is based on the '1995 statement of concensus on assessment of neurobehavioural outcomes after cardiac surgery'. This consensus statement describes the most reliable tests and study design to study POCD in clinical studies.

A battery of tests is described in the consensus statement:

  • Rey auditory verbal learning test for verbal memory
  • Trailmaking A and B for attention
  • Grooved pegboard test for fine motor function

In this study, two additional tests will be performed to assess POCD:

the digit span test to test the short term verbal memory. the digit symbol-coding test to test the processing speed and memory of the patient.

Additional recommendations of the consensus statement to conduct reliable POCD testing are:

  • Baseline testing
  • At least on assessment of POCD three months postoperatively
  • A control group and a comparative group
  • The same person tests both pre- and postoperatively
  • a clinical neurological investigation is necessary

Cerebrovascular accident (CVA or stroke) is caused by disturbances of the brain blood supply. The main causes of these disturbances are clotted vessels, hypoperfusion, or ruptured vessels in the brain. The risk of CVA is high in the first few days after cardiac surgery. CVA is diagnosed based on neurological evaluation and signs on CT or MRI scan.

Delirium is characterised by attention disorders and fluctuating changes in the mental state of the patient. Delirium is mainly related to surgery and can be diagnosed with the CAM-ICU (confusion assessment method for the intensive care unit).

These neurological complications have a negative effect on the quality of life, healthcare costs and mortality rate after cardiac surgery.

Recently, new developments in cardiac surgery hav led to the introduction of minimal invasive cardiac procedures into practice. These minimal invasive cardiac procedures are proven to be beneficial for the patient. Neurological outcome after minimal invasive cardiac surgery however, is not well studied.

Therefore, the main goal of this study is to examine the neurological outcome after endoscopic coronary artery bypass grafting (Endo-CABG). Endo-CABG is a minimal invasive cardiac procedure based on the conventional coronary artery bypass grafting (CABG) procedure.

Study design and study tests:

This study will be a single-centre prospective cohort study. The goal of the study is to assess the neurological outcome after endoscopic coronary artery bypass grafting (Endo-CABG). Three study groups will be included (described in section study groups), which will be tested for POCD, CVA and delirium.

Secondary outcomes in this research are quality of life of the patient (EQ-5D-5L), Fear and depression outcomes (VVO; CES-D), and assessment of demographic and peri-operative predictors of poor neurological outcome after endo-CABG.

Study tests:

Baseline tests will be performed in both intervention groups (Endo-CABG and PCI) and the healthy control group.

In the intervention groups the baseline preoperative tests will include:

  • Baseline neurocognitive status: mini mental test
  • Baseline EQ-5D: Quality of life
  • Baseline fear and depression state (VVO; CES-D)
  • Preoperative clinical neurological investigation
  • Baseline POCD status (Rey auditory verbal learning test,Trailmaking A \& B, Grooved pegboard test, Digit span test, Digit symbol-coding test)

For the healthy volunteers the same baseline tests will be performed, with exception of the neurological clinical evaluation.

Postoperative tests in the intervention groups will include:

  • Postoperative neurologic clinical evaluation (CT scan if CVA suspected), CAM-ICU): these tests will be performed at the ICU or ward
  • 3 months after surgery: EQ-5d (quality of life), Fear and depression, POCD follow-up (Rey auditory verbal learning test, Trailmaking A \& B, Grooved pegboard test, Digit span test, Digit symbol-coding test)

For the healthy volunteers, the following tests will be performed 3 months after baseline testing:

  • EQ-5d: quality of life
  • Stroke follow-up
  • Fear and depression
  • POCD status (Rey auditory verbal learning test,Trailmaking A \& B, Grooved pegboard test, Digit span test, Digit symbol-coding test)

Statistical analysis:

In this study POCD is defined as a decline in score between baseline and follow-up neurophysiological test, which should be higher than the natural variation. In this setting the natural learning effect will also be taken into account. To perform statistical analysis for POCD testing, Z-scores (or reliable change index (RCI)) will be used. The Z-score is a unit which indicates how the difference between the baseline score and the follow-up test behaves compared to the mean scores of the control group.

Thus, the individual RCI scores will be calculated as follows:

  • For each patient, the baseline score from each test will be subtracted from the follow-up score, giving Δx. The same will be done in the control group, giving Δxc. The mean change on that test in the control group will then be subtracted from Δx to eliminate practice effects.
  • This result will then be divided by the standard deviation of Δxc to eliminate the effect of natural variation in test performance. This is called a Z-score.

The RCI is the sum of the Z-scores of all tests.

We defined POCD in an individual patient as an RCI equal to or less than -1.645 (significance level 5%), or Z-score equal to or less than -1.645 in at least two different tests.

The group RCI scores will be compared using ANOVA or Kruskall-Wallis.

The quality of life will be tested using a mann-whitney U test at significance level 5%.

Being tested
Endo-CABG, PCI
Keywords
cardiac surgery, neurological outcome, minimal invasive coronary artery bypass graft (Endo-CABG)
Medical subject headings
Postoperative Cognitive Complications, Stroke, Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endo-CABGProcedure or surgery

    Also called minimal invasive Coronary Artery Bypass Grafting

    minimal invasive cardiac intervention

  • PCIProcedure or surgery

    Also called percutaneous coronary intervention

    stenting procedure

Study groups in NCT02979782
Study groupRoleWhat they receive
Endo-CABG, surgical groupthe minimal invasive cardiac surgery group
Receives: Procedure: Endo-CABG
PCI, comparative surgical groupa comparative minimal invasive procedure
Receives: Procedure: PCI
Healthy volunteer, control groupto exclude any learning effect or natural variation in neurological testing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of postoperative cognitive dysfunction

    percentage of total study population

    Measured: 3 months after intervention

  2. Prevalence of delirium

    percentage of total study population

    Measured: 3 months after intervention

  3. Prevalence of cerebrovascular accident

    percentage of total study population

    Measured: 3 months after intervention

Secondary outcomes (4)
  1. Quality of life of the patient

    assessment with the EQ-5D questionnaire

    Measured: 3 months after intervention

  2. assessment of predictors of poor neurological outcome after minimal invasive coronary artery bypass grafting

    assessment of which demographic and peri-operative variables are associated with poor neurological outcome after minimal invasive coronary

    Measured: 3 months after intervention

  3. Incidence of depression after minimal invasive coronary artery bypass grafting

    assessment with the CES-D questionnaire

    Measured: 3 months after intervention

  4. Incidence of fear after minimal invasive coronary artery bypass grafting

    assessment with the Surgical Fear Questionnaire

    Measured: 3 months after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2016 (estimated)
  2. Study startDec 2016
  3. Primary completionAug 2018
  4. Study completionAug 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
180 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02979782
Sponsor's protocol ID
16.115/anesth16.01
Acronym
NOMICS
Status last verified
Dec 2018
First submitted
23 Nov 2016
Last updated
14 Dec 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Likosky DS, Nugent WC, Ross CS; Northern New England Cardiovascular Disease Study Group. Improving outcomes of cardiac surgery through cooperative efforts: the northern new England experience. Semin Cardiothorac Vasc Anesth. 2005 Jun;9(2):119-21. doi: 10.1177/108925320500900203.

    PubMed 15920635
  • GILMAN S. CEREBRAL DISORDERS AFTER OPEN-HEART OPERATIONS. N Engl J Med. 1965 Mar 11;272:489-98. doi: 10.1056/NEJM196503112721001. No abstract available.

    PubMed 14250198
  • Furlan AJ, Sila CA, Chimowitz MI, Jones SC. Neurologic complications related to cardiac surgery. Neurol Clin. 1992 Feb;10(1):145-66.

    PubMed 1557000
  • Jensen BO, Hughes P, Rasmussen LS, Pedersen PU, Steinbruchel DA. Health-related quality of life following off-pump versus on-pump coronary artery bypass grafting in elderly moderate to high-risk patients: a randomized trial. Eur J Cardiothorac Surg. 2006 Aug;30(2):294-9. doi: 10.1016/j.ejcts.2006.04.015. Epub 2006 Jul 7.

    PubMed 16829089
  • Newman MF, Grocott HP, Mathew JP, White WD, Landolfo K, Reves JG, Laskowitz DT, Mark DB, Blumenthal JA; Neurologic Outcome Research Group and the Cardiothoracic Anesthesia Research Endeavors (CARE) Investigators of the Duke Heart Center. Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke. 2001 Dec 1;32(12):2874-81. doi: 10.1161/hs1201.099803.

    PubMed 11739990
  • Newman MF. Open heart surgery and cognitive decline. Cleve Clin J Med. 2007 Feb;74 Suppl 1:S52-5. doi: 10.3949/ccjm.74.suppl_1.s52. No abstract available.

    PubMed 17455545
  • Ottens TH, Dieleman JM, Sauer AM, Peelen LM, Nierich AP, de Groot WJ, Nathoe HM, Buijsrogge MP, Kalkman CJ, van Dijk D; DExamethasone for Cardiac Surgery (DECS) Study Group. Effects of dexamethasone on cognitive decline after cardiac surgery: a randomized clinical trial. Anesthesiology. 2014 Sep;121(3):492-500. doi: 10.1097/ALN.0000000000000336.

    PubMed 25225745
  • Modi P, Chitwood WR Jr. Retrograde femoral arterial perfusion and stroke risk during minimally invasive mitral valve surgery: is there cause for concern? Ann Cardiothorac Surg. 2013 Nov;2(6):E1. doi: 10.3978/j.issn.2225-319X.2013.11.13.

    PubMed 24350000
  • Stessel B, Nijs K, Pelckmans C, Vandenbrande J, Ory JP, Yilmaz A, Starinieri P, Van Tornout M, De Klippel N, Dendale P. Neurological outcome after minimally invasive coronary artery bypass surgery (NOMICS): An observational prospective cohort study. PLoS One. 2020 Dec 23;15(12):e0242519. doi: 10.1371/journal.pone.0242519. eCollection 2020.

    PubMed 33362277
  • Nijs K, Vandenbrande J, Vaqueriza F, Ory JP, Yilmaz A, Starinieri P, Dubois J, Jamaer L, Arijs I, Stessel B. Neurological outcome after minimal invasive coronary artery surgery (NOMICS): protocol for an observational prospective cohort study. BMJ Open. 2017 Oct 6;7(10):e017823. doi: 10.1136/bmjopen-2017-017823.

    PubMed 28988183

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Cognitive Dysfunction and Cerebrovascular Accident, run by Jessa Hospital at 2 sites in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of postoperative cognitive dysfunction (time frame: 3 months after intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02979782, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in